19-36073544-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001083961.2(WDR62):​c.1233+13C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0427 in 1,461,698 control chromosomes in the GnomAD database, including 1,604 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.036 ( 145 hom., cov: 31)
Exomes 𝑓: 0.043 ( 1459 hom. )

Consequence

WDR62
NM_001083961.2 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -1.55

Publications

4 publications found
Variant links:
Genes affected
WDR62 (HGNC:24502): (WD repeat domain 62) This gene is proposed to play a role in cerebral cortical development. Mutations in this gene have been associated with microencephaly, cortical malformations, and cognitive disability. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2011]
WDR62 Gene-Disease associations (from GenCC):
  • microcephaly 2, primary, autosomal recessive, with or without cortical malformations
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, Ambry Genetics, Illumina, G2P, ClinGen
  • autosomal recessive primary microcephaly
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 19-36073544-C-T is Benign according to our data. Variant chr19-36073544-C-T is described in ClinVar as Benign. ClinVar VariationId is 160245.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.105 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
WDR62NM_001083961.2 linkc.1233+13C>T intron_variant Intron 9 of 31 ENST00000401500.7 NP_001077430.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
WDR62ENST00000401500.7 linkc.1233+13C>T intron_variant Intron 9 of 31 1 NM_001083961.2 ENSP00000384792.1

Frequencies

GnomAD3 genomes
AF:
0.0358
AC:
5369
AN:
149890
Hom.:
142
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0218
Gnomad AMI
AF:
0.00887
Gnomad AMR
AF:
0.0286
Gnomad ASJ
AF:
0.0649
Gnomad EAS
AF:
0.112
Gnomad SAS
AF:
0.0810
Gnomad FIN
AF:
0.0318
Gnomad MID
AF:
0.0417
Gnomad NFE
AF:
0.0364
Gnomad OTH
AF:
0.0414
GnomAD2 exomes
AF:
0.0489
AC:
11518
AN:
235362
AF XY:
0.0503
show subpopulations
Gnomad AFR exome
AF:
0.0265
Gnomad AMR exome
AF:
0.0209
Gnomad ASJ exome
AF:
0.0673
Gnomad EAS exome
AF:
0.125
Gnomad FIN exome
AF:
0.0341
Gnomad NFE exome
AF:
0.0398
Gnomad OTH exome
AF:
0.0485
GnomAD4 exome
AF:
0.0435
AC:
56995
AN:
1311696
Hom.:
1459
Cov.:
31
AF XY:
0.0447
AC XY:
29326
AN XY:
656216
show subpopulations
African (AFR)
AF:
0.0232
AC:
708
AN:
30532
American (AMR)
AF:
0.0225
AC:
968
AN:
43034
Ashkenazi Jewish (ASJ)
AF:
0.0732
AC:
1776
AN:
24270
East Asian (EAS)
AF:
0.113
AC:
4134
AN:
36536
South Asian (SAS)
AF:
0.0784
AC:
6520
AN:
83182
European-Finnish (FIN)
AF:
0.0370
AC:
1721
AN:
46548
Middle Eastern (MID)
AF:
0.0490
AC:
264
AN:
5392
European-Non Finnish (NFE)
AF:
0.0385
AC:
38001
AN:
987626
Other (OTH)
AF:
0.0532
AC:
2903
AN:
54576
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.578
Heterozygous variant carriers
0
2770
5540
8311
11081
13851
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1502
3004
4506
6008
7510
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0359
AC:
5380
AN:
150002
Hom.:
145
Cov.:
31
AF XY:
0.0362
AC XY:
2649
AN XY:
73222
show subpopulations
African (AFR)
AF:
0.0218
AC:
896
AN:
41120
American (AMR)
AF:
0.0286
AC:
433
AN:
15152
Ashkenazi Jewish (ASJ)
AF:
0.0649
AC:
222
AN:
3420
East Asian (EAS)
AF:
0.112
AC:
566
AN:
5044
South Asian (SAS)
AF:
0.0807
AC:
380
AN:
4708
European-Finnish (FIN)
AF:
0.0318
AC:
324
AN:
10194
Middle Eastern (MID)
AF:
0.0448
AC:
13
AN:
290
European-Non Finnish (NFE)
AF:
0.0364
AC:
2443
AN:
67098
Other (OTH)
AF:
0.0458
AC:
95
AN:
2074
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.584
Heterozygous variant carriers
0
215
430
646
861
1076
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
70
140
210
280
350
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0248
Hom.:
16
Bravo
AF:
0.0338

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
Feb 08, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Microcephaly 2, primary, autosomal recessive, with or without cortical malformations Benign:2
Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:2
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
0.28
DANN
Benign
0.69
PhyloP100
-1.6
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs76130844; hg19: chr19-36564446; COSMIC: COSV54332745; COSMIC: COSV54332745; API